Baxter International Inc. vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| BAX | RMD | |
|---|---|---|
| Market Cap | $11.90 billion | $32.93 billion |
| Revenue (TTM) | $11.47 billion | $5.65 billion |
| Net Income (TTM) | $-1,063,000,000 | $1.52 billion |
RMD leads on 2 of 3 size & scale factors.
Valuation
| BAX | RMD | |
|---|---|---|
| P/E Ratio | — | 21.90 |
| Price / Book | 1.93 | 5.00 |
| Price / Sales | 1.04 | 5.82 |
BAX leads on 2 of 2 valuation factors.
Profitability
| BAX | RMD | |
|---|---|---|
| Net Margin | -9.27% | 26.94% |
| Return on Equity | -17.20% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| BAX | RMD | |
|---|---|---|
| Dividend Yield | 0.18% | 1.16% |
| Payout Ratio | — | 25.31 |
RMD leads on 1 of 1 dividend factors.
Risk & Sentiment
| BAX | RMD | |
|---|---|---|
| Short Interest | 1.03% | 4.04% |
BAX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.